HIV, SIV, Neuro AIDS

Journal of NeuroVirology, Volume 6 (2000) and Volume 7 (2001)

Publications by Topic

1. HIV, SIV NeuroAIDS (page 1)

2. HTLV-1 (page 5)

3. HSV (page 6)

4. JCV & PML (page 7)

5. Rabies (page 9)

6. BDV (page 9)

7. Measles (page 10)

8. Influenza, Theiler’s Virus and Coronavirus (page 10)

9. Moloney Murine Leukemia Virus & Other Retroviruses (page 10)

10. Chemokines & Cytokines (page 11)

11. Multiple Sclerosis (page 12)

12. Gene Delivery, Viral Vector (page 15)

13. Other Related Category (page 15)

1. HIV, SIV, Neuro AIDS

Nebuloni M, Pellegrinelli A, Ferri A, Tosoni A, Bonetto S, Zerbi P, Boldorini R, Vago L, Costanzi G. (2000). Etiology of microglial nodules in brains of patients with acquired immunodeficiency syndrome. J Neurovirol. 6(1):46-50.

Chong YH, Lee MJ. (2000). Expression of complement inhibitor protein CD59 in human neuronal and glial cell lines treated with HIV-1 gp41 peptides. J Neurovirol. 6(1):51-60.

Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC. (2000).

Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol. 6(1):84-8.

Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, Male D, Everall I. (2000). Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues.

J Neurovirol. 6(2):145-55.

Liuzzi GM, Mastroianni CM, Santacroce MP, Fanelli M, D'Agostino C, Vullo V, Riccio P. (2000). Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J Neurovirol. 6(2):156-63.

Smith KM, Crandall KA, Kneissl ML, Navia BA. (2000). PCR detection of host and HIV-1 sequences from archival brain tissue. J Neurovirol. 6(2):164-71.

Guillemin G, Croitoru J, Le Grand RL, Franck-Duchenne M, Dormont D, Boussin FD. (2000).

Simian immunodeficiency virus mac251 infection of astrocytes. J Neurovirol. 6(3):173-86.

Demuth M, Czub S, Sauer U, Koutsilieri E, Haaft P, Heeney J, Stahl-Hennig C, ter Meulen V, Sopper S. (2000). Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV.

J Neurovirol. 6(3):187-201.

Huang MB, Weeks O, Zhao LJ, Saltarelli M, Bond VC. (2000). Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures. J Neurovirol. 6(3):202-20.

Valle LD, Croul S, Morgello S, Amini S, Rappaport J, Khalili K. (2000). Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol. 6(3):221-8.

Hoffmann M, Berger JR, Nath A, Rayens M. (2000). Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa. J Neurovirol. 6(3):229-36.

Boven LA, Middel J, Breij EC, Schotte D, Verhoef J, Soderland C, Nottet HS. (2000).

Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines. J Neurovirol. 6(5):382-9.

Brouwers P, Civitello L, DeCarli C, Wolters P, Sei S. (2000). Cerebrospinal fluid viral load is related to cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease. J Neurovirol. 6(5):390-7.

Bjugstad KB, Flitter WD, Garland WA, Philpot RM, Kirstein CL, Arendash GW. (2000).

CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex. J Neurovirol. 6(6):478-91.

Chen H, Wood C, Petito CK. (2000). Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: potential role of choroid plexus in the pathogenesis of HIV encephalitis.

J Neurovirol. 6(6):498-506.

Kanmogne GD, Grammas P, Kennedy RC. (2000). Analysis of human endothelial cells and cortical neurons for susceptibility to HIV-1 infection and co-receptor expression. J Neurovirol. 6(6):519-28

Chen H, Wood C, Petito CK. (2000). Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: potential role of choroid plexus in the pathogenesis of HIV encephalitis.

J Neurovirol. 6(6):498-506.

Rostasy K, Monti L, Yiannoutsos C, Wu J, Bell J, Hedreen J, Navia BA. (2000). NFkappaB activation, TNF-alpha expression, and apoptosis in the AIDS-Dementia-Complex. J Neurovirol. 6(6):537-43

Powderly WG. (2000). Current approaches to treatment for HIV-1 infection. J Neurovirol. 6 Suppl 1:S8-S13.

Xiong H, Zeng YC, Lewis T, Zheng J, Persidsky Y, Gendelman HE. (2000) HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise:

relevance for HIV-1-associated dementia.J Neurovirol. 6 Suppl 1:S14-23.

Gabuzda D, Wang J. (2000). Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J Neurovirol. 6 Suppl 1:S24-32.

Royal W 3rd. (2000). Neurologic disease in injection drug users: therapeutic issues J Neurovirol. 6 Suppl 1:S33-7.

Gray F, Adle-Biassette H, Brion F, Ereau T, le Maner I, Levy V, Corcket G. (2000).

Neuronal apoptosis in human immunodeficiency virus infection. J Neuroviro 6 Suppl 1:S38-43.

Albright AV, Shieh JT, O'Connor MJ, Gonzalez-Scarano F. (2000). Characterization of cultured microglia that can be infected by HIV-1. J Neurovirol. 6 Suppl 1:S53-60.

Choe W, Albright A, Sulcove J, Jaffer S, Hesselgesser J, Lavi E, Crino P, Kolson DL. (2000).

Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells.

J Neurovirol. 6 Suppl 1:S61-9.

Liu Y, Tang XP, McArthur JC, Scott J, Gartner S. (2000). Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for

monocyte trafficking into brain. J Neurovirol. 6 Suppl 1:S70-81.

Wu DT, Woodman SE, Weiss JM, McManus CM, D'Aversa TG, Hesselgesser J, Major EO, Nath A, Berman JW. (2000). Mechanisms of leukocyte trafficking into the CNS. J Neurovirol. 6 Suppl 1:S82-5.

Messam CA, Major EO. (2000) Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue.. J Neurovirol. 6 Suppl 1:S90-4.

Cinque P, Bestetti A, Morelli P, Presi S. (2000). Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system. J Neurovirol. 6 Suppl 1:S95-S102.

Everall IP. (2000). Neuronal damage - recent issues and implications for therapy. J Neurovirol. 6 Suppl 1:S103-5.

Perez A, Probert AW, Wang KK, Sharmeen L. (2001). Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. J Neurovirol. 7(1):1-10.

Shieh TM, Carter DL, Blosser RL, Mankowski JL, Zink MC, Clements JE. (2001). Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J Neurovirol. 2001 Feb;7(1):11-24.

Kohleisen B, Hutzler P, Shumay E, Ovod V, Erfle V. (2001). HIV-1 Nef co-localizes with the astrocyte-specific cytoskeleton protein GFAP in persistently nef-expressing human astrocytes.

J Neurovirol. 2001 Feb;7(1):52-5.

Smith DG, Guillemin GJ, Pemberton L, Kerr S, Nath A, Smythe GA, Brew BJ. (2001).

Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J Neurovirol. 7(1):56-60.

Levin MC, Rosenblum MK, Fox CH, Jacobson S. (2001). Localization of retrovirus in the central nervous system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia. J Neurovirol. 7(1):61-5.

Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR. (2001). Acceleration of HIV dementia with methamphetamine and cocaine. J Neurovirol. 7(1):66-71.

Stins MF, Shen Y, Huang SH, Gilles F, Kalra VK, Kim KS. (2001) Gp120 activates children's brain endothelial cells via CD4. J Neurovirol. 7(2):125-34.

Schweighardt B, Shieh JT, Atwood WJ. (2001). CD4/CXCR4-independent infection of human astrocytes by a T-tropic strain of HIV-1. J Neurovirol. 7(2):155-62.

Piller SC. (2001). Effect of extracellular HIV-1 Vpr protein in vitro. J Neurovirol. 7(2):183-5. No abstract available.

Schweighardt B, Atwood WJ. (2001). Virus receptors in the human central nervous system. J Neurovirol. 7(3):187-95. Review.

Albright AV, Martin J, O'Connor M, Gonzalez-Scarano F. (2001). Interactions between HIV-1 gp120, chemokines, and cultured adult microglial cells. J Neurovirol. 7(3):196-207.

Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B. (2001).

HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J Neurovirol. 7(3):235-49.

Albright AV, Martin J, O'Connor M, Gonzalez-Scarano F. (2001). Interactions between HIV-1 gp120, chemokines, and cultured adult microglial cells. J Neurovirol. 7(3):196-207.

Antinori A, Ammassari A, Giancola ML, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F, Larussa D, Ippolito G, De Luca A. (2001). Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J Neurovirol. 7(4):323-8.

Berger JR, Chauhan A, Galey D, Nath A. (2001). Epidemiological evidence and molecular basis of interactions between HIV and JC virus. J Neurovirol. 7(4):329-38.

Geschwind M, Skolasky R, Royal W, McArthur J. (2001). The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS J Neurovirol. 7(4):353-7.

Cinque P, Pierotti C, Vigano MG, Bestetti A, Fausti C, Bertelli D, Lazzarin A. (2001). The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

J Neurovirol. 7(4):358-63.

De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G, Cauda R, Monforte A, Antinori A. (2001). Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study. J Neurovirol. 7(4):364-8.

Gasnault J, Kousignian P, Kahraman M, Rahoiljaon J, Matheron S, Delfraissy JF, Taoufik Y. (2001). Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: A monocenter observational study with clinical and JC virus load monitoring. J Neurovirol. 7(4):375-81.

Levy RM, Major E, Ali MJ, Cohen B, Groothius D. (2001) Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of

HIV-related progressive multifocal leukoencephalopathy (PML). J Neurovirol. 7(4):382-5.

Aksamit A. (2001). Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol. 7(4):386-90.

Andersson L, Hagberg L, Fuchs D, Svennerholm B, Gisslen M. (2001) Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals-correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels. J Neurovirol Dec;7(6):542-547.

Sung JH, Shin SA, Park HK, Montelaro RC, Chong YH. (2001). Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells. J Neurovirol. Oct;7(5):454-65.

Lokensgard JR, Hu S, Hegg CC, Thayer SA, Gekker G, Peterson PK. (2001). Diazepam inhibits HIV-1 Tat-induced migration of human microglia. J Neurovirol. Oct;7(5):481-6.

Nakagaki K, Nakagaki K, Takahashi K, Schols D, De Clercq E, Tabira T. (2001). CXCR4 is the primary receptor for feline immunodeficiency virus in astrocytes.

J Neurovirol. Oct;7(5):487-92.

Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, Richardson MW, Amini S, Morgello S, Khalili K, Rappaport J. (2001). CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol. Dec;7(6):528-541.

2. HTLV-l

Nakane S, Shirabe S, Moriuchi R, Mizokami A, Furuya T, Nishiura Y, Okazaki S, Yoshizuka N,

Suzuki Y, Nakamura T, Katamine S, Gojobori T, Eguchi K. (2000). Comparative molecular analysis of HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant

HTLV-I-associated myelopathy in monozygotic twins. J Neurovirol. 6(4):275-83.

Danaher RJ, Jacob RJ, Miller CS. (2000). Herpesvirus quiescence in neuronal cells: antiviral conditions not required to establish and maintain HSV-2 quiescence. J Neurovirol. 6(4):296-302.

Szymocha R, Brisson C, Bernard A, Akaoka H, Belin MF, Giraudon P. (2000) Long-term effects of HTLV-1 on brain astrocytes: sustained expression of Tax-1 associated with synthesis of inflammatory mediators. J Neurovirol. 6(4):350-7.

Matsuzaki T, Nakagawa M, Nagai M, Nobuhara Y, Usuku K, Higuchi I, Takahashi K, Moritoyo T, Arimura K, Izumo S, Akiba S, Osame M. (2000). HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations.

J Neurovirol. 6(6):544-8.

Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, Kubota H, Izumo S, Akiba S, Osame M. (2001). HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol. 7(3):228-34.

3. HSV

Millhouse S, Wigdahl B. (2000). Molecular circuitry regulating herpes simplex virus type 1 latency in neurons. J Neurovirol. 6(1): 6-24. Review.

Thompson KA, Blessing WW, Wesselingh SL. (2000). Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal Herpes

encephalitis. J Neurovirol. 6(1): 25-32.

Holmes KD, Cassam AK, Chan B, Peters AA, Weaver LC, Dekaban GA. (2000). A multi-mutant herpes simplex virus vector has minimal cytotoxic effects on the distribution of filamentous actin, alpha-actinin 2 and a glutamate receptor in differentiated PC12 cells. J Neurovirol. 6(1): 33-45.

Chowdhury SI, Lee BJ, Onderci M, Weiss ML, Mosier D. (2000). Neurovirulence of glycoprotein C(gC)-deleted bovine herpesvirus type-5 (BHV-5) and BHV-5 expressing BHV-1

gC in a rabbit seizure model. J Neurovirol. 6(4):284-95.

Danaher RJ, Jacob RJ, Miller CS. (2000). Herpesvirus quiescence in neuronal cells: antiviral conditions not required to establish and maintain HSV-2 quiescence. J Neurovirol. 6(4):296-302.

Boggian I, Buzzacaro E, Calistri A, Calvi P, Cavaggioni A, Mucignat-Caretta C, Palu G. (2000).

Asymptomatic herpes simplex type 1 virus infection of the mouse brain. J Neurovirol. 6(4):303-13.

Fukushi H, Taniguchi A, Yasuda K, Yanai T, Masegi T, Yamaguchi T, Hirai K. (2000). A hamster model of equine herpesvirus 9 induced encephalitis. J Neurovirol. 6(4):314-9.

Su YH, Moxley M, Kejariwal R, Mehta A, Fraser NW, Block TM. (2000). The HSV 1 genome in quiescently infected NGF differentiated PC12 cells can not be stimulated by HSV

superinfection. J Neurovirol. 6(4):341-9.

Yamamoto T, Nakamura Y. (2000). A single tube PCR assay for simultaneous amplification of HSV-1/-2, VZV, CMV, HHV-6A/-6B, and EBV DNAs in cerebrospinal fluid from patients with virus-related neurological diseases. J Neurovirol. 6(5):410-7.

Weir JP. (2001). Infection of human NT2 cells and differentiated NT-neurons with herpes simplex virus and replication-incompetent herpes simplex virus vectors. J Neurovirol. 7(1):43-51

Marques AR, Straus SE, Fahle G, Weir S, Csako G, Fischer SH. (2001). Lack of association between HSV-1 DNA in the brain, Alzheimer's disease and apolipoprotein E4. J Neurovirol. 7(1):82-3.